clorgyline has been researched along with Alloxan Diabetes in 1 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Umbarkar, P | 1 |
| Singh, S | 1 |
| Arkat, S | 1 |
| Bodhankar, SL | 1 |
| Lohidasan, S | 1 |
| Sitasawad, SL | 1 |
1 other study available for clorgyline and Alloxan Diabetes
| Article | Year |
|---|---|
Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
Topics: Animals; Antioxidants; Apoptosis; Clorgyline; Diabetes Mellitus, Experimental; Diabetic Cardiomyopat | 2015 |